Perceptions and Ultrasound Literacy for Sound Volume Management

NCT ID: NCT07237347

Last Updated: 2025-11-19

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Total Enrollment

200 participants

Study Classification

OBSERVATIONAL

Study Start Date

2025-12-01

Study Completion Date

2026-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to assess the knowledge, attitudes, and practices of ICU physicians in Switzerland regarding the use of ultrasound for fluid management and evaluation of venous congestion.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This multicenter survey study aims to explore the experiences, perceptions, and attitudes of intensive care unit (ICU) physicians in Switzerland regarding the use of ultrasound for fluid management. The primary objective is to assess participants' knowledge of ultrasound techniques to predict fluid responsiveness and evaluate venous congestion. The study will also compare familiarity with traditional methods (e.g., central venous pressure, IVC-Inferior Vena Cava ultrasound) and newer approaches such as the VEXUS (Venous Excess Ultrasound Score) score or assessment of stroke volume changes during passive leg raise or mini fluid challenges.

Participants will complete an online questionnaire via REDCap, covering demographics, professional background, ultrasound training, knowledge and experience with ultrasound for volume management and venous congestion, as well as institutional factors and suggestions for improvement. The survey will be distributed to physicians working in ICUs at multiple Swiss hospitals, including the University Hospital Basel, Kantonsspital Aarau, Inselspital Bern, Spitalzentrum Biel, and Triemlispital Zürich. Participation is voluntary, and informed consent will be obtained electronically at the start of the questionnaire.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Ultrasound-guided Fluid Management Volume Responsiveness Venous Congestion Assessment ICU Physician Practices

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

ICU staff

physicians working in ICUs in Switzerland

Quastionnaire

Intervention Type OTHER

physicians working in ICUs will complete a questionnaire through REDcap

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Quastionnaire

physicians working in ICUs will complete a questionnaire through REDcap

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* physicians working in ICUs
* working in Switzerland

Exclusion Criteria

\-
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University Hospital, Basel, Switzerland

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Gregor Loosen, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital of Basel

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University Hospital Basel

Basel, , Switzerland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Switzerland

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Gregor Loosen, MD

Role: CONTACT

+41 61 55 65194

Sebastian Berger, MD

Role: CONTACT

+41 61 32 84085

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Gregor Loosen, MD

Role: primary

+41 61 55 65194

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

am25Loosen;Req-2025-00684

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.